You Searched For "Globe Biotech" and got 20 results
Sort By:
Bangladesh might have Covid-19 vaccine by December, says Globe Biotech scientist
Claiming success in preliminary animal modelling trial of Covid-19 vaccine, Globe Biotech Limited…
Two 'devastated' couples are suing a biotech company after their IVF embryos were destroyed in a 'toxic' oil
An attorney told Insider he's fielded calls from approximately 50 people who say their embryos were…
Erin Snodgrass
Watch out for 4 IPOs opening on August 4— here’s a snapshot for each of the companies selling shares tomorrow
July saw some interesting IPOs, which got bumper listings on exchanges including Zomato, Clean Scie…
Healthcare's transformative leaders are looking to upend the industry by building on the pandemic's scientific advancements
Insider found 10 leaders meaningfully changing science and medicine. They're looking to build a sys…
Mohana Ravindranath
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
Indian government dismissed reports that claimed people who got the Covaxin jab may not qualify for travelling abroad
The Indian government on Saturday dismissed reports claiming that people who are fully vaccinated w…
Bharat Biotech's BSL-3 aims to produce 700 million doses of Covaxin per annum
Biotechnology major Bharat Biotechs BSL-3 (Biosafety Level-3) facilities will play a pivotal role i…
Moderna just laid out its strategy to fight coronavirus variants and says a new shot is ready to be tested
Moderna shipped a new version of its coronavirus vaccine to the NIH so that it could be tested in p…
Allison DeAngelis
6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results
While the British drugmaker said on Monday that its shot, developed with the University of Oxford, …
Andrew Dunn,Dr. Catherine Sch…
Bharat Biotech begins COVID-19 vaccine human trials in Rohtak
The human trial of Bharat Biotech's anti-COVID-19 vaccine Covaxin began at Rohtak's Post-Graduate I…
An Indian COVID-19 vaccine made by Bharat Biotech is set to enter human trials
India, on Monday (June 29) got the approval for conducting human trials of a potential coronavirus …
The first high-quality study of malaria pill hydroxychloroquine just found it doesn't help prevent coronavirus infections
Hydroxychloroquine didn't reduce the risk of infection in people exposed to coronavirus. President …
Andrew Dunn
An obscure biotech stock skyrockets 38% after saying it's testing a coronavirus antibody
The Monday gains for the company, which has a market value of about $2.8 billion, are a continuatio…
Carmen Reinicke
The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Andrew Dunn
'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time
Hartaj Singh, a biotech analyst at Oppenheimer who covers the company, thinks investors are still g…
Andrew Dunn
Silicon Valley's top biotech VCs share the biggest mistakes startups make when they pitch
But accomplishing these goals requires laying practical groundwork. In healthcare, that could mean …
Erin Brodwin
A biotech is proposing a plan to pay for its pricey rare disease treatment the same way you'd buy a TV or dishwasher - here's the inside story
But Leschly is confident that Bluebird can get through them. For one, beta thalassemia, which is ca…
Emma Court
The CEO of a $5.6 billion biotech that just had the year's best post-IPO pop told told us how it's partnering with Microsoft to build an enormous map of the human immune system
Robins founded Adaptive with his scientist brother in 2009. On Thursday, shares of the Seattle, Was…
Emma Court
The biggest biotech discovery of the century will make designer babies and genetically edited humans possible
Researchers are developing ways to use CRISPR to treat genetic conditions like sickle-cell anemia a…
Biotech Stock Kite Phama Explodes Higher After Good News About Its Non-Hodgkin's Lymphoma Drug
The findings from an ongoing Phase 1-2a clinical trial funded by Kite and conducted by the Surgery …